We are live on ! Find out more
MD icon

Pediatrix Medical

241 hedge funds and large institutions have $1.16B invested in Pediatrix Medical in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 80 increasing their positions, 85 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,331% more call options, than puts

Call options by funds: $2.67M | Put options by funds: $110K

75% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 20

7% more capital invested

Capital invested by funds: $1.08B → $1.16B (+$80.8M)

5% more funds holding

Funds holding: 229241 (+12)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

6% less repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 85

2.41% less ownership

Funds ownership: 95.82%93.41% (-2.4%)

Holders
241
Holders Change
+12
Holders Change %
+5.24%
% of All Funds
3.23%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
35
Increased
80
Reduced
85
Closed
20
Calls
$2.67M
Puts
$110K
Net Calls
+$2.56M
Net Calls Change
+$1.89M
Name Holding Trade Value Shares
Change
Change in
Stake
CWM
151
CIBC World Markets
New York
$277K +$272K +19,129 New
PFSRSONJ
152
Police & Firemen's Retirement System of New Jersey
New Jersey
$277K
OC
153
Oppenheimer & Co
New York
$270K -$23.4K -1,650 -8%
BP
154
Ballentine Partners
Massachusetts
$265K +$8.18K +576 +3%
Bank of Montreal
155
Bank of Montreal
Ontario, Canada
$263K +$46.2K +3,251 +22%
KK
156
KLP Kapitalforvaltning
Norway
$259K
CM
157
Capula Management
Cayman Islands
$250K +$245K +17,272 New
PNC Financial Services Group
158
PNC Financial Services Group
Pennsylvania
$249K -$866 -61 -0.4%
Two Sigma Advisers
159
Two Sigma Advisers
New York
$242K -$4.26K -300 -2%
DT
160
Diversified Trust
Tennessee
$236K +$232K +16,305 New
Balyasny Asset Management
161
Balyasny Asset Management
Illinois
$231K +$227K +15,967 New
AI
162
Atria Investments
North Carolina
$218K -$158K -11,152 -43%
HW
163
Hancock Whitney
Mississippi
$215K +$37.7K +2,656 +22%
VRS
164
Virginia Retirement Systems
Virginia
$206K +$202K +14,200 New
Pictet Asset Management
165
Pictet Asset Management
Switzerland
$205K -$5.68K -400 -3%
ECM
166
Everence Capital Management
Indiana
$201K
QCM
167
Quantinno Capital Management
New York
$196K +$15.8K +1,115 +9%
Public Employees Retirement Association of Colorado
168
Public Employees Retirement Association of Colorado
Colorado
$195K
Neuberger Berman Group
169
Neuberger Berman Group
New York
$194K -$2.74K -193 -1%
SPA
170
Sherbrooke Park Advisers
New York
$185K +$33.9K +2,389 +23%
Carson Wealth (CWM LLC)
171
Carson Wealth (CWM LLC)
Nebraska
$180K +$61.9K +4,361 +54%
SA
172
Sanctuary Advisors
Indiana
$180K -$84.1K -5,919 -32%
MOACM
173
Mutual of America Capital Management
New York
$178K -$7.03K -495 -4%
JF
174
Jump Financial
Illinois
$169K +$166K +11,677 New
OF
175
Optimize Financial
California
$167K +$164K +11,544 New

MD Hedge Fund Activity: Q1 2025 in Review

241 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q1 2025, worth a combined $1.16B — up 7.5% from $1.08B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new MD positions and 20 closed out — a net gain of 15 holders — while 80 added to existing stakes and 85 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $5.43M. The largest seller was Pacer Advisors, cutting an estimated $24.3M.

  • 241 institutional investors held Pediatrix Medical (MD) as of Q1 2025, up from 229 in Q4 2024.
  • Funds reported $1.16B of Pediatrix Medical stock for Q1 2025, up 7.5% quarter-over-quarter.
  • 35 funds opened new Pediatrix Medical positions in Q1 2025 and 20 closed out, a net change of +15 holders.
  • The largest Pediatrix Medical buyer in Q1 2025 was Renaissance Technologies, an estimated $5.43M added.
  • The largest Pediatrix Medical seller in Q1 2025 was Pacer Advisors, an estimated $24.3M sold.

Based on aggregated 13F filings for Q1 2025.